![Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12672-023-00628-z/MediaObjects/12672_2023_628_Fig4_HTML.png)
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink
![Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma - ScienceDirect Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523319301810-gr4.jpg)
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma - ScienceDirect
![Molecules | Free Full-Text | Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model Molecules | Free Full-Text | Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model](https://www.mdpi.com/molecules/molecules-28-00779/article_deploy/html/images/molecules-28-00779-g007.png)
Molecules | Free Full-Text | Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model
![The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells - Varon - 2019 - International Journal of Cancer - Wiley Online Library The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells - Varon - 2019 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c50f3b31-5fd7-4763-a2e5-8d21a370eae5/ijc32400-fig-0002-m.jpg)
The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells - Varon - 2019 - International Journal of Cancer - Wiley Online Library
![Frontiers | Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies Frontiers | Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies](https://www.frontiersin.org/files/Articles/589508/fonc-10-589508-HTML/image_m/fonc-10-589508-g001.jpg)
Frontiers | Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies
![Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma - ScienceDirect Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523319301810-gr1.jpg)
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma - ScienceDirect
![Cancers | Free Full-Text | Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups Cancers | Free Full-Text | Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups](https://www.mdpi.com/cancers/cancers-13-06323/article_deploy/html/images/cancers-13-06323-g001.png)
Cancers | Free Full-Text | Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups
![Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12672-023-00628-z/MediaObjects/12672_2023_628_Fig5_HTML.png)
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink
![Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12672-023-00628-z/MediaObjects/12672_2023_628_Fig1_HTML.png)
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink
![Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12672-023-00628-z/MediaObjects/12672_2023_628_Fig6_HTML.png)
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink
![Molecules | Free Full-Text | Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model Molecules | Free Full-Text | Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model](https://pub.mdpi-res.com/molecules/molecules-28-00779/article_deploy/html/images/molecules-28-00779-g002.png?1673524905)
Molecules | Free Full-Text | Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model
![Frontiers | Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma Frontiers | Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma](https://www.frontiersin.org/files/Articles/1007641/fcell-10-1007641-HTML-r1/image_m/fcell-10-1007641-g004.jpg)
Frontiers | Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma
![NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma | Cell Death & Disease NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-019-2026-y/MediaObjects/41419_2019_2026_Fig1_HTML.png)
NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma | Cell Death & Disease
![The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells - Varon - 2019 - International Journal of Cancer - Wiley Online Library The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells - Varon - 2019 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5f08d74d-32ab-43ee-825d-0336521c0dbc/ijc32400-fig-0001-m.jpg)